Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Durability and breadth of neutralisation following multiple antigen exposures to SARS-CoV-2 infection and/or COVID-19 vaccination
Alexander P. Underwood, Christina Sølund, Carlota Fernandez-Antunez, et al.
EBioMedicine (2023) Vol. 89, pp. 104475-104475
Open Access | Times Cited: 16

Showing 16 citing articles:

Antibody longevity and waning following COVID-19 vaccination in a 1-year longitudinal cohort in Bangladesh
Md. Ahsanul Haq, Anjan Kumar Roy, Razu Ahmed, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 8
Neutralizing antibody and CD8+ T cell responses following BA.4/5 bivalent COVID-19 booster vaccination in adults with and without prior exposure to SARS-CoV-2
Alexander P. Underwood, Christina Sølund, Kivin Jacobsen, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Neutralization of omicron subvariants and antigenic cartography following multiple COVID 19 vaccinations and repeated omicron non JN.1 or JN.1 infections
Nungruthai Suntronwong, Sitthichai Kanokudom, Thaneeya Duangchinda, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
T cell receptor usage and epitope specificity amongst CD8+ and CD4+ SARS-CoV-2-specific T cells
Ulrik Fahnøe, Shan Feng, Alexander P. Underwood, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Deep mutational learning for the selection of therapeutic antibodies resistant to the evolution of Omicron variants of SARS-CoV-2
Lester Frei, Beichen Gao, Jiami Han, et al.
Nature Biomedical Engineering (2025)
Open Access
Lessons from COVID‐19: Aspects of prevention, therapeutics, and diagnostics against SARS‐CoV‐2 with special focus on JN.1 and XBB sublineages
Puja Jaishwal, Upagya Gyaneshwari, Kisalay Jha, et al.
MedComm – Future Medicine (2024) Vol. 3, Iss. 2
Open Access | Times Cited: 1
An inactivated SARS-CoV-2 vaccine based on a Vero cell culture-adapted high-titer virus confers cross-protection in small animals
Anna Offersgaard, Carlos R. Duarte Hernandez, Yuyong Zhou, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Omicron COVID-19 immune correlates analysis of a third dose of mRNA-1273 in the COVE trial
Bo Zhang, Youyi Fong, Jonathan Fintzi, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Neutralisation Resistance of SARS-CoV-2 Spike-Variants is Primarily Mediated by Synergistic Receptor Binding Domain Substitutions
Long V. Pham, Alexander P. Underwood, Alekxander Binderup, et al.
Emerging Microbes & Infections (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Deep learning-guided selection of antibody therapies with enhanced resistance to current and prospective SARS-CoV-2 Omicron variants
Lester Frei, Beichen Gao, Jiami Han, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
Long-Term Immunity Against SARS-CoV-2 Wild Type and Omicron XBB 1.5 in Indonesian Residents after Vaccination and Infection
Karismananda Karismananda, Ammar Abdurrahman Hasyim, Akihiko Sakamoto, et al.
(2024)
Open Access | Times Cited: 1
Pediatric antibody responses to SARS-CoV-2 after infection and vaccination in Calgary, Canada
Leah J. Ricketson, Emily J. Doucette, Isabella Alatorre, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access
Long-Term Immunity against SARS-CoV-2 Wild-Type and Omicron XBB.1.5 in Indonesian Residents after Vaccination and Infection
Karismananda Karismananda, Ammar Abdurrahman Hasyim, Akihiko Sakamoto, et al.
Antibodies (2024) Vol. 13, Iss. 3, pp. 72-72
Open Access
Broadly potent spike-specific human monoclonal antibodies inhibit SARS-CoV-2 Omicron sub-lineages
Melanie R. Walker, Alexander P. Underwood, Kasper H. Björnsson, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access
Difference in the Dynamics of Antibody Titer between COVID-19 Vaccination and SARS-CoV-2 Infection in Healthcare Workers –A Case Study Based on Long-Term and Dense Measurement of Antibody Titer
Hirotaka Tanaka, Hiroyuki Sawatari, Shin‐ichi Ando
Japanese Journal of Infectious Diseases (2023) Vol. 77, Iss. 1, pp. 51-54
Open Access
Novel, broad and potent spike-specific human monoclonal antibodies inhibit SARS-CoV-2 Omicron sub-lineages
Melanie R. Walker, Alexander P. Underwood, Sai Sundar Rajan Raghavan, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top